Burcon Nutrascience Corp Stock Price, News & Analysis

Burcon NutraScience (OTCQB: BRCNF) has announced the successful commercial production of Puratein®C, its high-purity canola protein isolate, at the Galesburg facility. The product, featuring over 90% protein content, is now available for immediate customer delivery.

Puratein®C is produced from non-GMO North American canola seeds and boasts a complete amino acid profile with a PDCAAS score of 1. The product's characteristics include high solubility, light cream color, and mild flavor, making it suitable for various applications including dairy alternatives, beverages, meat analogues, and nutraceuticals.

Burcon NutraScience (OTCQB: BRCNF) announced its upcoming annual general and special meeting scheduled for September 17, 2025. The company is seeking shareholder approval for a significant warrant repricing initiative to amend the exercise price of all outstanding warrants to $3.50 per Common Share.

The warrant amendments affect three tranches: 644,043 May 2023 warrants (current price $5.89), 603,094 March 2024 warrants (current price $4.544), and 297,112 Advisory warrants (current price $4.544). CEO Kip Underwood highlighted the company's commercial progress, noting over 150 active customer projects in final evaluation stages.

Due to insider holdings, the amendments require disinterested shareholder approval with separate voting for each warrant tranche, excluding votes from warrant holders and their affiliates.

Burcon NutraScience (OTCQB: BRCNF), a plant-based protein technology company, reported its fiscal 2026 Q1 results with notable progress in commercialization. The company generated revenue of $342,000, a 44% increase year-over-year, driven by initial protein sales and contract manufacturing services at its Galesburg facility.

Key achievements include securing a $6.8 million multi-year production agreement, first commercial production of Peazazz® C pea protein and FavaPro™ fava protein, and facility integration. However, the company reported a net loss of $3.5 million ($0.27 per share) and had $4.2 million in cash as of June 30, 2025. Burcon maintains its calendar 2025 revenue target of $1-3 million.

Burcon NutraScience (OTCQB: BRCNF) has announced the successful commercial production and launch of FavaPro™, a high-purity fava protein isolate containing over 90% protein content. The product, developed through Burcon's proprietary extraction process, is designed for food, beverage, and nutraceutical applications.

FavaPro™ features a neutral flavor profile and off-white color, making it suitable for various applications including dairy alternatives, nutritional beverages, snacks, and baked goods. The protein is derived from fava beans, which are nitrogen-fixing crops that improve soil health and reduce synthetic fertilizer requirements. The product received significant interest at the recent IFT FIRST tradeshow, highlighting strong market demand.

Burcon NutraScience (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, has announced the appointment of Ms. Alex Varty as Interim Chief Financial Officer, effective August 4, 2025. She succeeds Mr. Robert Peets, who served as CFO since July 2024.

Ms. Varty, who joined Burcon in February 2024, brings significant experience in finance and accounting, including senior roles at KPMG LLP. She is a Chartered Professional Accountant with a Bachelor of Science in Biotechnology/Chartered Professional Accounting from the University of Waterloo. The transition comes as Burcon continues its evolution into a revenue-generating, innovation company.

Burcon NutraScience (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, has scheduled its fiscal 2026 first quarter earnings conference call for August 13, 2025, at 5:00 p.m. Eastern time. The company will release its financial results for the quarter ended June 30, 2025, before the call.

CEO Kip Underwood highlighted that Burcon is transitioning from a technology pioneer to a revenue-generating innovation leader in plant protein. Following IFT FIRST, the company has experienced increased customer engagement and is scaling production at its Galesburg facility to meet growing market demand.

Burcon NutraScience (OTCQB: BRCNF), a leader in plant-based protein innovation, will showcase its new Chipotle Black Bean Protein Hummus at the 2025 IFT FIRST Annual Event & Expo in Chicago from July 13-16, 2025. The hummus features a proprietary triple blend of the company's 90%+ pure proteins: Peazazz®C pea protein, Puratein®C canola protein, and Solatein™ sunflower protein.

Visitors to booth S4066 can sample the hummus during special tasting events on July 14-15 from 11 AM to 1 PM. The company will also showcase its Café Latte Plant Protein Beverage and complete portfolio of plant-based proteins, including hemp and fava bean proteins, all featuring neutral flavor profiles and smooth mouthfeel.

Burcon NutraScience (OTCQB: BRCNF) will showcase its innovative plant protein portfolio at the 2025 IFT FIRST Annual Event & Expo in Chicago from July 13-16. The company will feature a new Café Latte beverage concept containing 10 grams of protein per eight-ounce serving, made with their proprietary blend of Peazazz®C pea protein and Solatein™ sunflower protein.

At booth S4066, Burcon will display its complete range of high-purity plant proteins, including products derived from pea, canola, sunflower, hemp, and fava beans. All proteins feature 90%+ purity, neutral flavor, and excellent functionality for various food and beverage applications.

Burcon NutraScience (OTCQB: BRCNF) reported its fiscal 2025 results, marking a transformative year in its transition from innovation to commercial execution. The company recorded revenue of $381,000 and a net loss of $8.3 million ($1.06 per share). Key achievements include forming a strategic alliance with ProMan for the Galesburg protein facility acquisition, raising $9.4 million through a rights offering, and securing a $6.8 million multi-year production agreement.

The company launched several new protein products including Puratein®C canola protein, Peazazz®C pea protein, and Solatein™ sunflower protein. With over 100 prospective customers evaluating their proteins, Burcon targets $1-3 million revenue for calendar 2025 and expects profitability by calendar 2026. The company ended the fiscal year with $7.3 million in cash.